Latest Trials
| EudraCT Number: 2005-000380-26 | Sponsor Protocol Number: CERTES02 (Ce-PoP-RAD001A2419) | Start Date: 2005-05-24 | |||||||||||
| Sponsor Name: Novartis Farmacéutica S.A. | |||||||||||||
| Full Title: A 12 month, multicenter, randomized, parallel, open-label study, to evaluate renal function and efficacy of Certican® (everolimus) with Simulect® (basiliximab) and cyclosporine discontinuation at 3... | |||||||||||||
| Medical condition: Renal Transplant | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||